Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
暂无分享,去创建一个
Ben Berkhout | Pavlina Konstantinova | Mustafa Ceylan | B. Berkhout | P. Konstantinova | M. Ceylan | O. ter Brake | Olivier ter Brake
[1] A. Kingsman,et al. A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1gag-pol Gene , 2000, Journal of virology.
[2] Anastasia Khvorova,et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets , 2006, Nature Methods.
[3] B. Berkhout,et al. Inhibition of virus replication by RNA interference. , 2003, Journal of biomedical science.
[4] Dieter Huesken,et al. Design of a genome-wide siRNA library using an artificial neural network , 2005, Nature Biotechnology.
[5] B. Berkhout. RNA interference as an antiviral approach: targeting HIV-1. , 2004, Current opinion in molecular therapeutics.
[6] M. Emerman,et al. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. , 1991, Virology.
[7] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[8] B. Berkhout,et al. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs , 2005, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.
[9] J. Rossi,et al. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA , 2004, Nature Biotechnology.
[10] R. Cortese,et al. Transcription by RNA polymerase III. , 1983, Current topics in developmental biology.
[11] T. Du,et al. Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.
[12] R. Kirkman,et al. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. , 2004, Virology.
[13] B. Clotet,et al. Sequence Homology Required by Human Immunodeficiency Virus Type 1 To Escape from Short Interfering RNAs , 2006, Journal of Virology.
[14] B. Cullen,et al. Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary Macrophages by Using Tat- or CCR5-Specific Small Interfering RNAs Expressed from a Lentivirus Vector , 2003, Journal of Virology.
[15] Theresa A. Storm,et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.
[16] B. Berkhout,et al. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA , 2006, Gene Therapy.
[17] A. Reynolds,et al. Rational siRNA design for RNA interference , 2004, Nature Biotechnology.
[18] J. Rossi,et al. Novel Pol II Fusion Promoter Directs Human Immunodeficiency Virus Type 1-Inducible Coexpression of a Short Hairpin RNA and Protein , 2006, Journal of Virology.
[19] D. Trono,et al. Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.
[20] Joshua N. Leonard,et al. Computational Design of Antiviral RNA Interference Strategies That Resist Human Immunodeficiency Virus Escape , 2005, Journal of Virology.
[21] J. Lieberman,et al. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. , 2005, Blood.
[22] Ben Berkhout,et al. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome , 2005, Nucleic acids research.
[23] M. Sioud. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. , 2005, Journal of molecular biology.
[24] S. Akira,et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.
[25] B. Harder,et al. Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. , 2001, Human gene therapy.
[26] K. Metzner,et al. Inhibition of drug-resistant HIV-1 by RNA interference. , 2006, Antiviral research.
[27] Ali Ehsani,et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.
[28] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[29] M. Stevenson,et al. Modulation of HIV-1 replication by RNA interference , 2002, Nature.
[30] R. Surabhi,et al. RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication , 2002, Journal of Virology.
[31] D. Trono,et al. A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.
[32] B. Ramratnam,et al. Human Immunodeficiency Virus Type 1 Escape from RNA Interference , 2003, Journal of Virology.
[33] R. Pomerantz,et al. Antiviral Effects of Human Immunodeficiency Virus Type 1-Specific Small Interfering RNAs against Targets Conserved in Select Neurotropic Viral Strains , 2004, Journal of Virology.
[34] J. Rossi,et al. Sensing the danger in RNA , 2005, Nature Medicine.
[35] J. Seppen,et al. Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. , 2002, Journal of hepatology.
[36] John J Rossi,et al. Control of HIV-1 replication by RNA interference. , 2004, Virus research.
[37] L. Everitt,et al. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] John J Rossi,et al. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] Helen M Blau,et al. Restriction enzyme–generated siRNA (REGS) vectors and libraries , 2004, Nature Genetics.
[40] M. Iino,et al. Enzymatic production of RNAi libraries from cDNAs , 2004, Nature Genetics.
[41] D. Weissman,et al. Inhibition of HIV-1 Infection by Small Interfering RNA-Mediated RNA Interference1 , 2002, The Journal of Immunology.
[42] Transcription by RNA Polymerase III , 1988 .
[43] J. He,et al. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1 , 2005, Gene Therapy.
[44] R. Iggo,et al. Determinants of interferon-stimulated gene induction by RNAi vectors. , 2004, Differentiation; research in biological diversity.
[45] R. Iggo,et al. Induction of an interferon response by RNAi vectors in mammalian cells , 2003, Nature Genetics.
[46] T. Tuschl,et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate , 2001, The EMBO journal.
[47] Claes Wahlestedt,et al. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites , 2005, Nucleic acids research.
[48] J. Church,et al. siRNA-DIRECTED INHIBITION OF HIV-1 INFECTION , 2003, Pediatrics.
[49] Ben Berkhout,et al. Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition , 2004, Journal of Virology.
[50] L. Lim,et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. , 2006, RNA.
[51] D. R. Kuritzkes,et al. Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from Patients Treated with the Protease Inhibitor Nelfinavir , 1998, Antimicrobial Agents and Chemotherapy.